Trabectedin for recurrent grade 2 or 3 meningiomas

Neuro-Oncology: The Podcast - A podcast by Neuro-Oncology - Fridays

Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in Neuro-Oncology in October 2021.